Welcome to POWERbreathe - a hand-held inspiratory muscle trainer, which is a unique, easy-to-use, drug free product designed to help reduce breathlessness, improve fitness and maximise sports performance. POWERbreathe is the result of nearly a decade of research, and was designed by professional exercise scientists at Birmingham University and Loughborough University, UK.
How many of us get out-of-breath walking upstairs, running for a bus or walking the dog? There can be many causes of breathlessness, such as illness, injury or simply getting older.
Most people assume breathing is controlled automatically, like our heartbeat, but the truth is that we need to learn how to breathe well.
New research has shown that exercising and strengthening the muscles we use to breathe in - the inspiratory muscles - can help reduce breathlessness and can also alleviate the symptoms of asthma.
POWERbreathe has been shown to reduce breathlessness and bring new-found freedom to people who, because of illness or advancing age, are restricted by shortness of breath. Using the laboratory-proven POWERbreathe training system of 30 BREATHS TWICE A DAY, the strength of your breathing muscles will improve rapidly. An easy-to-use, drug free, hand-held device, POWERbreathe has a controllable load for progressive exercise and is appropriate for people at all levels of fitness.
Relieves the symptoms of ASTHMA
POWERbreathe is great for asthmatics, or anyone who suffers from respiratory problems. Numerous research trials have already been conducted, examining breathlessness and respiratory muscle fatigue in many groups of people. In randomised, controlled trials, on mild / moderate asthmatics, POWERbreathe increased inspiratory muscle strength by a mean of 11% in just 3 weeks (McConnell et al., 1998)
Inspiratory muscle training has improved inspiratory muscle function in the following conditions:
- Spinal cord injury (Huldtgren et al., 1980, Gross et al., 1980)
- Cystic fibrosis (Sawyer et al., 1993)
- Chronic heart failure (Cahalin et al., 1997, Mancini et al., 1995)
- Neuromuscular diseases including MS (Foglio et al., 1994), Duchenne muscular dystrophy (Wanke et al., 1994)
- Heart-lung transplant patients (Ambrosino et al., 1996)
Further Information: